[ad_1] Leave Oprah alone. Yes, Oprah Winfrey is in the news again — in this…
Weight Management
-
-
STOCK MARKET
Oprah’s departure from Weight Watchers’ board is the latest bad news for the stock, amid weight-loss-drug frenzy
by userby user[ad_1] Shares of WW International Inc., better known as Weight Watchers, tumbled after hours on…
-
STOCK MARKET
Viking Therapeutics’ weight-loss drug data makes company takeover target
by userby user[ad_1] Viking Therapeutics Inc.’s stock rose another 8% Wednesday to extend its week-to-date gains to…
-
STOCK MARKET
Viking Therapeutics’ stock doubles after company reports positive results in trial of weight-loss drug
by userby user[ad_1] Viking Therapeutics Inc.’s stock soared 100% early Tuesday, after the company announced positive results…
-
STOCK MARKET
Hims & Hers’ stock jumps on hopes of first profitable year, as it floats opportunities in weight loss
by userby user[ad_1] Shares of Hims & Hers Health Inc. rallied after hours on Monday, after the…
-
STOCK MARKET
Viking Therapeutics may offer investors a cheap entry to the weight-loss drug craze
by userby user[ad_1] Viking Therapeutics Inc.’s stock soared 17% to a record high on Thursday, after the…
-
[ad_1] A record number of people in the U.S. will turn 65 this year. Here’s…
-
STOCK MARKET
Ozempic and other weight-loss drugs’ popularity set these stocks up for big gains
by userby user[ad_1] Investors have such high hopes for popular weight-loss medications like Wegovy and Ozempic, the…
-
STOCK MARKET
4 things the best diets of 2024 have in common — and where Ozempic and Wegovy fit in
by userby user[ad_1] Losing weight is one of the top New Year’s resolutions that people make year…
-
STOCK MARKET
Five obesity-drug trends to watch in 2024: Who can compete with Eli Lilly and Novo Nordisk?
by userby user[ad_1] The obesity drugs that powered huge investor gains in 2023 are poised to inspire…